CD44 and Alzheimer disease: One signaling pathway, the macrophage migration inhibitory factor (MIF) pathway, has been implicated in the progression of various inflammatory diseases, including AD.[6, 7] MIF, a proinflammatory cytokine secreted by inflammatory fibroblasts, interacts with its receptors CD74 and CD44 to drive immune cell activation and inflammatory responses.